These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32218808)

  • 1. Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors.
    Gu Y; Mohammad IS; Liu Z
    Oncol Lett; 2020 Apr; 19(4):2585-2594. PubMed ID: 32218808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs.
    Kim BH; Won C; Lee YH; Choi JS; Noh KH; Han S; Lee H; Lee CS; Lee DS; Ye SK; Kim MH
    Biochem Pharmacol; 2013 Oct; 86(7):950-9. PubMed ID: 23962443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the STAT pathway in head and neck cancer: recent advances and future prospects.
    Nikitakis NG; Siavash H; Sauk JJ
    Curr Cancer Drug Targets; 2004 Dec; 4(8):637-51. PubMed ID: 15578920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
    Buettner R; Mora LB; Jove R
    Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.
    Heppler LN; Frank DA
    Trends Cancer; 2017 Dec; 3(12):816-827. PubMed ID: 29198438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges.
    Arshad S; Naveed M; Ullia M; Javed K; Butt A; Khawar M; Amjad F
    Genet Mol Biol; 2020; 43(1):e20180160. PubMed ID: 32167126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal Transducers and Activators of Transcription: Novel Targets for Anticancer Therapeutics.
    Bowman T; Yu H; Sebti S; Dalton W; Jove R
    Cancer Control; 1999 Oct; 6(5):427-435. PubMed ID: 10758575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription.
    Catlett-Falcone R; Dalton WS; Jove R
    Curr Opin Oncol; 1999 Nov; 11(6):490-6. PubMed ID: 10550013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer.
    Singh N; Hussain S; Bharadwaj M; Kakkar N; Singh SK; Sobti RC
    J Recept Signal Transduct Res; 2012 Dec; 32(6):321-7. PubMed ID: 23134344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT proteins as novel targets for cancer drug discovery.
    Turkson J
    Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis.
    Trivedi S; Starz-Gaiano M
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30558204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].
    Espert L; Dusanter-Fourt I; Chelbi-Alix MK
    Bull Cancer; 2005 Oct; 92(10):845-57. PubMed ID: 16266868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
    Saydmohammed M; Joseph D; Syed V
    J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling.
    Ahmad A; Sarkar SH; Aboukameel A; Ali S; Biersack B; Seibt S; Li Y; Bao B; Kong D; Banerjee S; Schobert R; Padhye SB; Sarkar FH
    Carcinogenesis; 2012 Dec; 33(12):2450-6. PubMed ID: 22971573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib.
    Derenzini E; Younes A
    Expert Opin Investig Drugs; 2013 Jun; 22(6):775-85. PubMed ID: 23442043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK/STAT Pathway in Skeletal Muscle Pathophysiology.
    Moresi V; Adamo S; Berghella L
    Front Physiol; 2019; 10():500. PubMed ID: 31114509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.